{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:36:16Z","timestamp":1762911376690,"version":"3.45.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001588","name":"Enterprise Ireland","doi-asserted-by":"publisher","award":["CF-2016-0428-P"],"award-info":[{"award-number":["CF-2016-0428-P"]}],"id":[{"id":"10.13039\/501100001588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection Prevention in Practice"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.infpip.2021.100153","type":"journal-article","created":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T01:30:23Z","timestamp":1622943023000},"page":"100153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of the microbial load of airway clearance devices used by a cohort of children with cystic fibrosis"],"prefix":"10.1016","volume":"3","author":[{"given":"B.","family":"Linnane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.H.","family":"O'Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Obande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.S.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.J.","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.P.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.infpip.2021.100153_bib1","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3928\/19382359-20190327-01","article-title":"Review of cystic fibrosis","volume":"48","author":"Goetz","year":"2019","journal-title":"Pediatr Ann"},{"issue":"9","key":"10.1016\/j.infpip.2021.100153_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/17474124.2018.1502663","article-title":"Gastrointestinal pathophysiology and nutrition in cystic fibrosis","volume":"12","author":"Ratchford","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"10059","key":"10.1016\/j.infpip.2021.100153_bib3","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.infpip.2021.100153_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/bbrj.bbrj_81_17","article-title":"Geographical distribution of cystic fibrosis; the past 70 years of data analysis","volume":"1","author":"Mirtajani","year":"2017","journal-title":"Biomed Biotechnol Res J"},{"issue":"1","key":"10.1016\/j.infpip.2021.100153_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1183\/09031936.00196314","article-title":"Future trends in cystic fibrosis demography in 34 European countries","volume":"46","author":"Burgel","year":"2015","journal-title":"Eur Resp J"},{"issue":"5","key":"10.1016\/j.infpip.2021.100153_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcf.2008.03.007","article-title":"The prevalence of cystic fibrosis in the European Union","volume":"7","author":"Farrell","year":"2008","journal-title":"J\u00a0Cystic Fibrosis"},{"issue":"1","key":"10.1016\/j.infpip.2021.100153_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00018-016-2393-9","article-title":"Cystic fibrosis: a clinical view","volume":"74","author":"Castellani","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.infpip.2021.100153_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1513\/pats.2306018","article-title":"Relationship of airway epithelial ion transport to chronic bronchitis","volume":"1","author":"Boucher","year":"2004","journal-title":"Proc Am Thorac Soc"},{"issue":"12","key":"10.1016\/j.infpip.2021.100153_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nrmicro2907","article-title":"Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective","volume":"10","author":"Folkesson","year":"2012","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.infpip.2021.100153_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011044","article-title":"Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients","volume":"5","author":"Cox","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.infpip.2021.100153_bib11","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1128\/JCM.42.11.5176-5183.2004","article-title":"Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling","volume":"42","author":"Rogers","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.infpip.2021.100153_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jcf.2016.01.004","article-title":"Microbial colonization and lung function in adolescents with cystic fibrosis","volume":"15","author":"Hector","year":"2016","journal-title":"J\u00a0Cystic Fibrosis"},{"key":"10.1016\/j.infpip.2021.100153_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12890-015-0113-0","article-title":"A\u00a0case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosa","volume":"15","author":"Linnane","year":"2015","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.infpip.2021.100153_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1755-7682-1-24","article-title":"Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers","volume":"1","author":"Coutinho","year":"2008","journal-title":"Int Arch Med"},{"issue":"12","key":"10.1016\/j.infpip.2021.100153_bib15","doi-asserted-by":"crossref","first-page":"e109798","DOI":"10.1371\/journal.pone.0109798","article-title":"The microbial community of the cystic fibrosis airway is disrupted in early life","volume":"9","author":"Renwick","year":"2014","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.infpip.2021.100153_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1183\/09031936.01.00068901","article-title":"Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF","volume":"18","author":"Navarro","year":"2001","journal-title":"Eur Resp J"},{"issue":"2","key":"10.1016\/j.infpip.2021.100153_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.infpip.2021.100153_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1086\/318075","article-title":"Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis","volume":"183","author":"Burns","year":"2001","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.infpip.2021.100153_bib19","first-page":"1392","article-title":"Airway clearance: physiology, pharmacology, tech-niques, and practice","volume":"52","author":"Hess","year":"2007","journal-title":"Respir Care"},{"issue":"1","key":"10.1016\/j.infpip.2021.100153_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.chest.2018.03.057","article-title":"Children with cystic fibrosis may be performing oscillating positive expiratory pressure therapy incorrectly","volume":"154","author":"O\u2019Sullivan","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.infpip.2021.100153_bib21","article-title":"Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis","volume":"11","author":"McIlwaine","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.infpip.2021.100153_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhin.2017.04.015","article-title":"Medical devices for cystic fibrosis care may be portable reservoirs of potential pathogens","volume":"96","author":"Linnane","year":"2017","journal-title":"J\u00a0Hosp Infect"},{"issue":"4","key":"10.1016\/j.infpip.2021.100153_bib23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4187\/respcare.06329","article-title":"Oscillating positive expiratory pressure therapy may be performed poorly by children with cystic fibrosis","volume":"64","author":"O\u2019Sullivan","year":"2019","journal-title":"Respir Care"},{"issue":"2","key":"10.1016\/j.infpip.2021.100153_bib24","first-page":"124","article-title":"Performance comparison of two oscillating positive expiratory pressure devices: acapella versus flutter","volume":"48","author":"Volsko","year":"2003","journal-title":"Resp Care"},{"issue":"1","key":"10.1016\/j.infpip.2021.100153_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1378\/chest.114.1.171","article-title":"Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage","volume":"114","author":"App","year":"1998","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.infpip.2021.100153_bib26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ppul.1950020608","article-title":"Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis","volume":"2","author":"Oberwaldner","year":"1986","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.infpip.2021.100153_bib27","first-page":"423","article-title":"Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis","volume":"65","author":"Falk","year":"1984","journal-title":"Eur J Respir Dis"},{"issue":"5","key":"10.1016\/j.infpip.2021.100153_bib28","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1378\/chest.100.5.1350","article-title":"The effects of postural drainage and positive expiratory pressure physiotherapy on tracheobronchial clearance in cystic fibrosis","volume":"100","author":"Mortensen","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.infpip.2021.100153_bib29","first-page":"241","article-title":"Short-term effects of positive expiratory pressure and the forced expiration technique on mucus clearance and lung function in CF [abstract]","volume":"Suppl 9","author":"Falk","year":"1993","journal-title":"Pediatr Pulmonol"},{"issue":"12","key":"10.1016\/j.infpip.2021.100153_bib30","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/ptj\/85.12.1278","article-title":"Physiologic evidence for high-frequency chest wall oscillation and positive expiratory pressure breathing in hospitalized subjects with cystic fibrosis","volume":"85","author":"Darbee","year":"2005","journal-title":"Physical Therapy"},{"issue":"6","key":"10.1016\/j.infpip.2021.100153_bib31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1067\/mpd.2001.114017","article-title":"Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis","volume":"138","author":"McIlwaine","year":"2001","journal-title":"J\u00a0Pediatr"},{"issue":"9","key":"10.1016\/j.infpip.2021.100153_bib32","first-page":"CD011699","article-title":"Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis","volume":"9","author":"Lee","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.infpip.2021.100153_bib33","article-title":"Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis","volume":"6","author":"McIlwaine","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"year":"2008","series-title":"Guideline for disinfection and sterilization in healthcare facilities","key":"10.1016\/j.infpip.2021.100153_bib34"},{"issue":"Rr-3","key":"10.1016\/j.infpip.2021.100153_bib35","first-page":"1","article-title":"Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee","volume":"53","author":"Tablan","year":"2004","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"10.1016\/j.infpip.2021.100153_bib36","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4187\/respcare.03513","article-title":"Device cleaning and infection control in aerosol\u00a0therapy","volume":"60","author":"O\u2019Malley","year":"2015","journal-title":"Respir Care"},{"issue":"3 Suppl","key":"10.1016\/j.infpip.2021.100153_bib37","first-page":"S1","article-title":"Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission","volume":"31","author":"Saiman","year":"2003","journal-title":"Am J Infect Control"},{"issue":"4","key":"10.1016\/j.infpip.2021.100153_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/1479972317707652","article-title":"Cleaning and infection control of airway clearance devices used by CF patients","volume":"14","author":"Manor","year":"2017","journal-title":"Chron Respir Dis"},{"year":"2010","series-title":"Laboratory standards for processing microbiological samples from people with cystic fibrosis: report of the UK cystic fibrosis trust microbiology laboratory standards working group","author":"Denton","key":"10.1016\/j.infpip.2021.100153_bib39"},{"issue":"2","key":"10.1016\/j.infpip.2021.100153_bib40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jcf.2015.05.002","article-title":"A\u00a0novel culture medium for isolation of rapidly-growing mycobacteria from the sputum of patients with cystic fibrosis","volume":"15","author":"Preece","year":"2016","journal-title":"J\u00a0Cystic Fibrosis"},{"issue":"9","key":"10.1016\/j.infpip.2021.100153_bib41","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/319987","article-title":"Nontuberculous mycobacteria in patients with cystic fibrosis","volume":"32","author":"Oliver","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.infpip.2021.100153_bib42","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1099\/jmm.0.030619-0","article-title":"Identification and characterization of breakthrough contaminants associated with the conventional isolation of Mycobacterium tuberculosis","volume":"60","author":"McClean","year":"2011","journal-title":"J\u00a0Med Microbiol"},{"issue":"7","key":"10.1016\/j.infpip.2021.100153_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1753465817710596","article-title":"Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection","volume":"11","author":"Greenwood","year":"2017","journal-title":"Ther Adv Respir Dis"},{"issue":"S45","key":"10.1016\/j.infpip.2021.100153_bib44","article-title":"Microbial contamination profile of TOBI\u00ae PodhalerTM versus nebulizers used in cystic fibrosis patients with chronic pseudomonas aeruginosa infection: a real world study","volume":"vol. 51","author":"Greenwood","year":"2016","journal-title":"Pediatr pulmonol 30th annual North American cystic fibrosis conference"},{"issue":"4","key":"10.1016\/j.infpip.2021.100153_bib45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2214.2006.00669.x","article-title":"Microbial contamination of nebulizers in the home treatment of cystic fibrosis","volume":"33","author":"Blau","year":"2007","journal-title":"Child Care Health Dev"},{"issue":"2","key":"10.1016\/j.infpip.2021.100153_bib46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1128\/JCM.38.2.724-726.2000","article-title":"Survival of enterococci and staphylococci on hospital fabrics and plastic","volume":"38","author":"Neely","year":"2000","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.infpip.2021.100153_bib47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4187\/aarc0446","article-title":"Infection control in cystic fibrosis: cohorting, cross-contamination, and the respiratory therapist","volume":"54","author":"O\u2019Malley","year":"2009","journal-title":"Respir Care"},{"issue":"6","key":"10.1016\/j.infpip.2021.100153_bib48","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1378\/chest.121.6.1754","article-title":"Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis","volume":"121","author":"Graff","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.infpip.2021.100153_bib49","first-page":"CD009249","article-title":"Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis","volume":"7","author":"Amin","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.infpip.2021.100153_bib50","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1473-3099(09)70083-0","article-title":"Stenotrophomonas maltophilia: an emerging opportunist human pathogen","volume":"9","author":"Looney","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.infpip.2021.100153_bib51","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1128\/JCM.40.5.1884.2002","article-title":"Molecular epidemiology of Stenotrophomonas maltophilia isolated from cystic fibrosis patients","volume":"40","author":"Denton","year":"2002","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.infpip.2021.100153_bib52","article-title":"Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem","volume":"45","author":"Riquena","year":"2019","journal-title":"J\u00a0Bras Pneumol"}],"container-title":["Infection Prevention in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590088921000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590088921000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:31:41Z","timestamp":1762911101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590088921000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2590088921000421"],"URL":"https:\/\/doi.org\/10.1016\/j.infpip.2021.100153","relation":{},"ISSN":["2590-0889"],"issn-type":[{"type":"print","value":"2590-0889"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the microbial load of airway clearance devices used by a cohort of children with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Infection Prevention in Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.infpip.2021.100153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.","name":"copyright","label":"Copyright"}],"article-number":"100153"}}